128 related articles for article (PubMed ID: 2713956)
1. CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.
Schieweck K; Stanek J; Kanter PM; Schmidt-Ruppin KH; Müller M; Matter A
Cancer Chemother Pharmacol; 1989; 23(6):341-7. PubMed ID: 2713956
[TBL] [Abstract][Full Text] [Related]
2. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
Sava G; Giraldi T
Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a bifunctional derivative of nitrosoalkylurea on the growth of experimetal tumors].
Vasil'eva LS; Gumanov LL; D'iachkovskaia RF; Konovalova NP; Surkova NI
Izv Akad Nauk SSSR Biol; 1973; 5():737-9. PubMed ID: 4796871
[No Abstract] [Full Text] [Related]
6. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
7. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
Hisamatsu T; Uchida S
Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
[TBL] [Abstract][Full Text] [Related]
9. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review.
Carter SK; Schabel FM; Broder LE; Johnston TP
Adv Cancer Res; 1972; 16():273-332. PubMed ID: 4563045
[No Abstract] [Full Text] [Related]
10. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
Shimizu F; Arakawa M
Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
[TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
[No Abstract] [Full Text] [Related]
12. Antitumor effect of 3-[3-(2-chloroethyl)-3-nitrosoureido]-3-deoxy-D-glucopyranose on murine tumors.
Komiyama K; Edanami K; Kuroda T; Umezawa I
Gan; 1981 Feb; 72(1):53-9. PubMed ID: 6456168
[TBL] [Abstract][Full Text] [Related]
13. CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.
Fiebig HH; Widmer KH; Winterhalter BR; Löhr GW
Cancer Chemother Pharmacol; 1989; 23(6):337-40. PubMed ID: 2713955
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of the nitrosoureas.
Wasserman TH; Slavik M; Carter SK
Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a new compound, ethyl O-[N-(p-carboxyphenyl)-carbamoyl]-mycophenolate, against various experimental tumors upon oral administration.
Mitsui H; Matsuno T; Ogawa H; Shiio T; Yugari Y; Tamura G
Gan; 1981 Feb; 72(1):66-71. PubMed ID: 7274650
[TBL] [Abstract][Full Text] [Related]
16. [Bifunctional derivatives of N-nitroso-alkylurea].
Emanuel' NM; Konovalova NP; D'iachkovskaia RF; Rozenberg AN
Vopr Onkol; 1976; 22(10):72-7. PubMed ID: 1014497
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
[TBL] [Abstract][Full Text] [Related]
19. Two glycine containing 2-chloroethylnitrosoureas--a comparative study on some physicochemical properties, in vivo antimelanomic effects and immunomodulatory properties.
Zheleva A; Stanilova S; Dobreva Z; Zhelev Z
Int J Pharm; 2001 Jul; 222(2):237-42. PubMed ID: 11427354
[TBL] [Abstract][Full Text] [Related]
20. Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars.
Roger P; Monneret C; Fournier JP; Choay P; Gagnet R; Gosse C; Letourneux Y; Atassi G; Gouyette A
J Med Chem; 1989 Jan; 32(1):16-23. PubMed ID: 2909727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]